---
date: "2024-01-01"
title: Treatment of Primary ITP in Adults
---

# Treatment of Primary ITP in Adults

[[objectives_of_itp_treatment.md|Objectives of ITP Treatment]]

- [[First-line or upfront therapy for idiopathic thrombocytopenic purpura]]
- Corticosteroids:
  - Prednisone (0.5-2 mg/kg/day) is commonly used as the initial therapy  Used with tapering based on response
  - Dexamethasone (40 mg PO daily x 4 days for 1-3 cycles)
  - Overall response:54 %vs 43% (P=.44)
  - Adverse event rates:
    - High-dose dexamethasone:24%
    - Standard-dose prednisone:46%
- [[frontline_rituximab_in_itp.md|Frontline Rituximab in ITP]]
- Intravenous immunoglobulin used at 0.8-1.0 g/kg for 1 dose:
  - Consider use for patients needing rapid platelet increase (eg, those with active bleeding) or those who cannot tolerate steroids
  - Anti-D immunoglobulin used at 50-75 μg/kg IV for 1 dose
- [[Second-line or maintainence therapy for idiopathic thrombocytopenic purpura]]
- [[Chronic or refractory for idiopathic thrombocytopenic purpura]]
- [[Bleeding Treatment for idiopathic thrombocytopenic purpura]]
